interferoninduc
transmembran
ifitm
protein
famili
group
antivir
restrict
factor
impair
flexibl
inhibit
membran
fusion
plasma
endosom
membran
restrict
viral
progress
entri
ifitm
wide
known
inhibit
sever
singlestrand
rna
virus
limit
report
avail
regard
effect
doublestrand
dna
virus
work
analyz
possibl
antivir
function
ifitm
doubl
strand
dna
viru
african
swine
fever
viru
asfv
infect
celladapt
asfv
isol
ifn
sensit
induc
ifitm
express
interestingli
high
level
ifitm
caus
collaps
endosom
pathway
perinuclear
area
given
asfv
entri
strongli
depend
endocytosi
investig
whether
ifitm
express
could
impair
viral
infect
express
reduc
viru
infect
vero
cell
impact
viral
entryunco
role
inhibit
asfv
vero
cell
could
relat
impair
endocytosismedi
viral
entri
alter
cholesterol
efflux
suggest
act
late
endosom
prevent
decapsid
stage
asfv
upon
infect
pathogen
bacteria
virus
host
cell
activ
innat
immun
respons
first
line
defens
group
cytokin
known
interferon
ifn
play
major
role
cell
immun
induc
cascad
interferonstimul
gene
isg
encod
sever
antivir
innat
immun
effector
among
isg
interferoninduc
transmembran
protein
ifitm
known
inhibit
entri
wide
varieti
envelop
rna
virus
group
protein
present
across
wide
rang
speci
amphibian
fish
bird
mammal
ifitm
human
identifi
year
ago
interferonstimul
gene
upon
induct
typei
typeii
ifn
human
express
almost
everi
cellular
type
wherea
express
primarili
osteoblast
requir
bone
miner
ifitm
found
mainli
distribut
plasma
membran
andor
endosom
membran
gene
cluster
chromosom
encod
rel
small
protein
amino
acid
extracytoplasm
termini
separ
two
transmembran
domain
cytoplasm
loop
cil
cil
well
conserv
ifitm
protein
larg
group
member
protein
famili
ifitm
current
known
inhibit
replic
multipl
rna
virus
enter
host
cell
via
endocytosi
includ
influenza
viru
iav
west
nile
viru
wnv
dengu
viru
denv
sever
acut
respiratori
syndrom
coronaviru
sar
cov
hepat
c
viru
hcv
contrast
ifitm
inhibit
entri
process
mous
leukemia
viru
mlv
machupo
viru
mach
lassa
viru
lasv
lymphocyt
choriomening
viru
lcmv
littl
known
ifitmmedi
antivir
activ
dna
virus
recent
describ
inhibit
rana
grylio
viru
rgv
frogfish
iridoviru
entri
stage
hand
report
affect
replic
dna
virus
human
papillomaviru
hpv
human
cytomegaloviru
hcmv
adenoviru
antivir
effect
ifitm
mainli
exert
effect
endocyt
pathway
would
affect
virus
enter
cell
late
endosom
compart
expand
understand
antivir
activ
ifitm
dna
virus
investig
role
protein
replic
cycl
african
swine
fever
viru
asfv
belong
nucleocytoplasm
larg
dna
viru
ncldv
superfamili
asfv
infect
strongli
depend
endocyt
pathway
thu
possibl
ifitmmedi
inhibit
viru
could
like
occur
endosom
compart
asfv
member
asfarvirida
famili
respons
highli
lethal
hemorrhag
diseas
affect
domest
swine
often
result
import
econom
loss
mani
countri
due
high
rate
mortal
associ
ill
lack
effect
vaccin
epidem
outbreak
current
affect
east
europ
slowli
spread
neighbor
countri
previous
report
asfv
enter
host
cell
dynamindepend
clathrinmedi
endocytosi
thu
goal
current
work
test
whether
ifitm
famili
protein
affect
earli
entri
step
asfv
infect
vero
cell
cultur
use
celladapt
isol
vero
cell
obtain
american
type
cultur
collect
atcc
richmond
va
usa
maintain
dulbecco
modifi
eagl
medium
supplement
fetal
bovin
serum
fb
luml
penicillin
streptomycin
lglutamin
co
cell
pretreat
uml
univers
typei
ifn
pbl
assay
scienc
h
indic
tissu
cultureadapt
asfv
isol
use
experi
flow
cytometri
analys
recombin
viru
express
viral
protein
fuse
green
fluoresc
protein
gfp
use
prepar
viral
stock
titrat
infect
procedur
carri
vero
cell
previous
describ
synchron
viral
infect
requir
adsorpt
phase
took
place
allow
viral
attach
cell
surfac
imped
intern
indic
asfv
semipurifi
sucros
cushion
pb
min
gener
stabl
cell
line
express
differ
protein
commerci
avail
lentivir
express
vector
plvxpuro
clontech
use
clone
protein
interest
cell
transfect
confluenc
use
lipofectamin
life
technolog
optimem
life
technolog
plate
plate
previous
pretreat
polyllysin
sigmaaldrich
final
concentr
mgml
avoid
cell
detach
cotransfect
plvxpuro
express
vector
togeth
vesicular
stomat
viru
glycoprotein
vsvg
human
immunodefici
viru
hiv
gagpol
express
plasmid
perform
produc
pseudotyp
lentivir
vector
supernat
contain
pseudotyp
lentivirus
collect
twice
h
h
postransfect
cell
debri
remov
brief
centrifug
rpm
min
clear
supernat
store
use
subconflu
vero
cell
transduc
pseudotyp
lentivirus
express
gene
interest
supplement
polybren
emd
millipor
h
later
transduc
cell
select
ad
puromycin
life
technolog
optim
puromycin
work
concentr
previous
titrat
nontransduc
cell
final
protein
express
level
vero
stablecel
line
determin
western
blot
wb
cell
seed
grown
glass
coverslip
mockinfect
infect
cell
fix
paraformaldehyd
pb
min
room
temperatur
rt
follow
cell
fixat
aldehyd
fluoresc
quench
incub
cell
mm
nh
cl
pb
min
cell
permeabil
triton
saponin
sigma
min
rt
block
bovin
serum
albumin
bsa
sigma
normal
goat
serum
sigma
cell
stain
primari
secondari
antibodi
incub
molecular
probe
pb
ratio
dna
stain
wash
coverslip
final
mount
glass
plate
cell
observ
leica
tc
confoc
microscop
leicamicrosystem
wetzlar
germani
use
immers
oil
object
detect
cholesterol
distribut
use
filipin
stain
sigma
previous
describ
cholesterol
visual
convent
leica
dm
rb
microscop
combin
immers
oil
object
uv
filter
set
imag
captur
leica
applic
suit
advanc
fluoresc
softwar
la
af
imagej
softwar
final
digit
imag
process
adob
photoshop
primari
antibodi
use
immunofluoresc
assay
includ
follow
rabbit
polyclon
antibodi
proteintech
antiasfv
mous
monoclon
antibodi
kindli
given
dr
jm
escribano
inia
asfv
mous
monoclon
antibodi
clone
immunofluoresc
clone
wb
clone
ingenasa
mous
monoclon
development
studi
hybridoma
bank
univers
iowa
clone
rabbit
polyclon
abcam
rabbit
polyclon
cell
signal
secondari
antibodi
purchas
molecular
probe
dilut
specif
label
absenc
signal
crossov
determin
examin
singl
label
control
sampl
cell
harvest
sampl
buffer
laemmli
concentr
sigma
sampl
incub
min
resolv
sdspage
polyacrylamidebisacrylamid
gel
afterward
separ
protein
transfer
nitrocellulos
membran
biorad
nonspecif
antibodi
bind
site
block
skim
milk
dilut
pb
incub
specif
primari
hrp
horseradish
peroxidas
conjug
secondari
antibodi
antibodi
use
western
blot
includ
rabbit
polyclon
proteintech
antiasfv
mous
monoclon
antibodi
antiasfv
mous
monoclon
antibodi
clone
ingenasa
mous
monoclon
tubulin
sigmaaldrich
secondari
antibodi
antimous
igg
ge
healthcar
antirabbit
igg
biorad
conjug
horseradish
peroxidas
use
dilut
precis
protein
streptactinhrp
conjug
biorad
use
reveal
ladder
precis
plu
protein
westernc
biorad
load
control
antimous
antibodi
sigma
use
final
band
obtain
develop
ecl
reagent
ge
healthcar
piscataway
nj
usa
detect
use
chemidoc
xrsplu
imag
system
biorad
band
densitometri
perform
imag
lab
softwar
biorad
normal
control
valu
quantit
number
copi
asfv
genom
achiev
quantit
realtim
pcr
qpcr
use
specif
oligonucleotid
premix
extaq
tm
takara
probe
fluoresc
hybrid
probe
use
amplifi
region
viral
gene
describ
previous
dna
cell
mockinfect
infect
asfv
moi
pfucel
extract
hpi
purifi
dnaeasi
blood
tissu
kit
qiagen
dna
concentr
measur
use
nanodrop
amplif
mixtur
prepar
ice
follow
ng
templat
dna
dilut
mq
h
total
volum
oligonucleotid
pmol
oligonucleotid
pmol
pcr
premix
ex
taq
tm
takara
taqman
probe
pmol
posit
amplif
control
includ
dna
purifi
asfv
purifi
virion
differ
concentr
standard
neg
amplif
control
consist
dna
mockinfect
cell
sampl
includ
triplic
valu
normal
standard
posit
control
reaction
perform
use
abi
fast
realtim
pcr
system
appli
biosystem
follow
paramet
cycl
min
cycl
cycl
min
studi
virion
decapsid
asfv
protocol
adapt
previou
public
briefli
stabl
cell
line
control
cell
contain
empti
vector
infect
moi
pfucel
viral
synchron
minut
enabl
viru
attach
cell
restrict
viral
entri
infect
allow
proceed
minut
co
cell
wash
cold
pb
treat
trypsinedta
gibco
minut
remov
membranebound
viru
final
cell
place
media
contain
fc
quench
trypsin
activ
wash
pb
treatment
intern
virion
observ
immunofluoresc
assay
describ
use
specif
antibodi
detect
major
viral
capsid
protein
viral
core
protein
stain
analyz
confoc
microscopi
decapsid
virion
singl
label
count
condit
normal
total
number
fulli
encapsid
virion
doubl
label
stabl
cell
line
control
cell
contain
empti
vector
infect
indic
moi
recombin
recombin
asfv
express
green
fluoresc
protein
fusion
protein
viral
sampl
infect
hpi
fix
wash
fac
buffer
three
time
analysi
vero
cell
infect
hpi
hpi
earli
late
postinfect
time
respect
harvest
trypsin
wash
fac
buffer
contain
pb
sodium
azid
bovin
serum
albumin
fix
permeabil
bd
scienc
min
rt
final
incub
specif
primari
antibodi
min
secondari
antibodi
use
phycoerythrin
pe
conjug
dako
dilut
fac
buffer
min
repeat
wash
cell
tube
analyz
facscalibur
flow
cytomet
bd
scienc
triplic
obtain
infect
rate
alway
normal
correspond
control
bonferroni
multiplecomparison
test
use
compar
differ
experiment
group
prism
softwar
graphpad
softwar
inc
softwar
use
statist
analysi
valu
express
graph
bar
mean
least
three
independ
experi
unless
otherwis
note
metric
normal
control
valu
repres
graphic
asterisk
denot
statist
signific
differ
p
p
p
determin
effect
interferon
asfv
infect
vero
cell
pretreat
uml
univers
typei
ifn
pbl
assay
scienc
h
later
infect
recombin
asfv
moi
pfucel
fig
viral
infect
quantifi
analyz
number
gfpposit
cell
flow
cytometri
hpi
fig
pretreat
vero
cell
univers
typei
ifn
concentr
complet
abrog
asfv
infect
compar
untreat
control
cell
sampl
flow
cytometri
profil
shown
fig
ifn
treatment
induc
express
ifitm
protein
ifitm
protein
locat
differ
cellular
compart
antivir
properti
strongli
correl
capac
alter
fluiditi
fusion
abil
membran
resid
analyz
ifitm
express
distribut
vero
cell
upon
ifn
treatment
end
cell
incub
either
uml
univers
typei
ifn
h
ifitm
distribut
analyz
confoc
microscopi
fig
although
basal
level
detect
prior
treatment
analyz
express
upon
ifn
treatment
vero
cell
incub
univers
typei
ifn
h
analyz
wb
fig
induc
ifn
cell
line
fig
show
highest
induct
fig
order
analyz
possibl
impact
ifitm
asfv
infect
gener
vero
cell
stabli
express
human
hereinaft
refer
cell
respect
control
cell
contain
empti
vector
gener
stabl
cell
line
use
lentivir
transduct
system
protein
interest
clone
plvx
vector
see
materi
method
section
detail
experiment
procedur
posit
transduc
vero
stabl
cell
select
puromycin
cell
establish
express
differ
ifitm
protein
confirm
wb
analysi
fig
shown
correspond
wb
densitometri
fig
highest
express
level
within
ifitm
famili
member
correspond
follow
assess
express
level
veroifitm
cell
next
want
ascertain
subcellular
distribut
ifitm
express
veroifitm
cell
compar
distribut
ifitm
vero
cell
empti
vector
confoc
microscopi
experi
reveal
mainli
distribut
plasma
membran
lesser
extent
perinuclear
compart
resembl
endosom
structur
fig
lower
left
panel
endogen
bare
detect
vero
cell
contain
empti
vector
fig
upper
left
panel
cell
overexpress
led
high
accumul
protein
perinuclear
region
coloc
vesicular
structur
resembl
endosom
fig
medium
lower
panel
consist
fig
signific
express
endogen
control
vero
cell
contain
empti
vector
display
mitochondrialik
pattern
togeth
vesicularlik
structur
final
overexpress
found
predominantli
accumul
perinuclear
region
show
pattern
consist
local
cluster
endosom
structur
fig
lower
right
panel
endogen
bare
detect
vero
cell
contain
empti
vector
fig
upper
right
panel
analysi
endogen
express
control
vero
cell
suggest
mix
mitochondri
vesicular
pattern
confirm
observ
analyz
subcellular
local
use
mitotrack
red
specif
marker
mitochondria
confoc
imag
reveal
distribut
mitochondri
structur
cell
contain
empti
vector
fig
howev
cell
label
local
endosomallik
structur
found
area
coloc
mitochondria
fig
investig
possibl
mechan
underli
inhibit
caus
ifitm
viral
infect
analyz
vesicular
local
ifitm
studi
cell
data
express
three
independ
experi
statist
signific
evalu
oneway
anova
follow
bonferroni
multipl
comparison
test
differ
mark
asterisk
indic
p
exampl
typic
fac
profil
shown
b
confoc
fluoresc
imag
subcellular
distribut
untreat
vero
cell
upon
increas
univers
ifn
concentr
h
bar
fig
endosom
normal
distribut
cytoplasm
dispers
distribut
found
differ
matur
stage
endosom
control
cell
howev
cell
dispers
distribut
chang
endosom
aggreg
around
nucleu
fig
endosom
redistribut
analyz
confoc
microcopi
x
z
plane
measur
mean
distanc
endosom
marker
cell
nucleu
use
distanc
measur
imagej
plugin
fig
total
cell
analyz
condit
conclud
overexpress
alter
endosom
distribut
accumul
vesicl
perinuclear
region
similar
pattern
previous
found
ifn
treatment
vero
cell
fig
redistribut
might
reflect
alter
endolysosom
matur
function
next
analyz
coloc
rate
ifitm
endosom
structur
remain
mainli
associ
intracellular
vesicular
membran
particularli
abund
endosom
structur
call
multivesicular
bodi
mvb
constitut
late
acid
endosom
compart
fill
intralumin
vesicl
ilv
ilv
fill
cholesterol
crucial
endosom
membran
backfus
necessari
late
endosom
matur
costain
ifitm
immunofluoresc
assay
reveal
clear
coloc
ifitm
veroifitm
cell
coloc
cell
cell
fig
lesser
extent
locat
primarili
endosom
compart
indic
higher
coloc
endosom
marker
fig
compar
empti
vector
fig
ifitm
protein
could
reduc
curvatur
cell
membran
fusion
pore
format
outer
endosom
membran
also
call
endosomallimit
membran
differenti
membran
intralumin
vesicl
insid
multivesicular
bodi
mvble
would
lead
alter
membran
fusion
impair
cholesterol
endosom
efflux
chang
endosom
distribut
found
ifitm
stabli
express
cell
fig
characterist
phenotyp
alter
cholesterol
endosom
efflux
convers
conserv
endosom
cholesterol
efflux
requir
correct
endosom
function
therefor
analyz
intracellular
intraendosom
cholesterol
level
use
cholesterol
marker
filipin
cell
show
intens
intracellular
cholesterol
accumul
perinuclear
area
fig
absent
control
cell
contain
empti
vector
fig
cholesterol
accumul
also
coloc
ifitmlabel
endosom
vesicl
contrast
cell
discret
coloc
area
cholesterol
found
plasma
membran
collect
find
indic
overexpress
vero
cell
result
cholesterol
accumul
endosom
compart
result
might
respons
alter
endosom
function
possibl
alter
viral
entri
pathway
next
investig
whether
overexpress
ifitm
could
restrict
asfv
infect
asfv
known
requir
acid
endosom
compart
entri
host
cell
success
asfv
entri
egress
endosom
depend
acid
ph
late
endosom
previou
experi
laboratori
reveal
inhibit
acidif
impair
viral
decapsid
viral
particl
retain
late
endosom
thu
block
viral
infect
progress
given
ifitm
restrict
could
mediat
endocyt
pathway
hypothes
ifitm
overexpress
may
affect
viru
entri
process
subsequ
asfv
infect
acid
ph
late
endosom
compart
requir
viral
decapsid
first
step
requir
uncoat
previou
endosom
escap
viru
start
replic
asf
virion
compos
sever
concentr
domain
viral
capsid
form
major
capsid
protein
organ
capsom
henc
decapsid
stain
virion
lost
intern
core
compos
nucleoid
contain
genom
coat
core
shell
thick
protein
layer
label
antibodi
core
shell
protein
deriv
process
core
shell
polypeptid
b
chang
distribut
quantifi
measur
mean
distanc
nucleu
differ
endosom
marker
x
z
plane
describ
materi
method
section
shown
graphic
distanc
reduc
cell
graphic
depict
n
cell
per
condit
statist
signific
evalu
oneway
anova
follow
bonferroni
multipl
comparison
test
differ
mark
asterisk
indic
p
p
use
antibodi
major
viral
capsid
protein
detect
viral
capsid
viral
core
protein
detect
viral
core
fig
analyz
number
encapsid
viral
particl
doubl
label
compar
number
success
decapsid
viral
core
posit
minut
postinfect
mpi
time
point
virion
undergo
uncoat
progress
replic
normal
condit
otherwis
encapsid
virion
would
accumul
confoc
microscopi
reveal
number
viral
core
sever
decreas
cell
compar
control
cell
contain
empti
vector
fig
doublelabel
encapsid
viral
particl
count
ratio
decapsid
viral
core
compar
total
number
virion
per
individu
cell
calcul
express
percentag
fig
percentag
decapsid
viru
sever
decreas
express
howev
express
produc
accumul
virion
lead
higher
number
total
virion
fig
increas
number
total
virion
might
result
impair
progress
asfv
replic
cycl
virion
would
neither
proceed
infect
degrad
would
consist
inhibit
membran
fusion
capac
endosom
level
altogeth
result
indic
viral
entri
ratelimit
step
cell
asfv
infect
final
analyz
impact
ifitm
express
infect
paramet
find
reduc
number
copi
asfv
genom
hpi
fig
ifitm
overexpress
induc
consist
reduct
infect
measur
earli
protein
express
flow
cytometri
fig
howev
reduct
even
mark
analyz
infect
cell
percentag
late
protein
express
fig
final
also
analyz
viral
protein
express
wb
fig
express
protein
hpi
fig
hpi
fig
result
significantli
reduc
infect
paramet
present
work
studi
antivir
effect
ifitm
famili
protein
context
celladapt
asfv
infect
vero
cell
differ
ifitm
protein
repeatedli
describ
inhibitor
broad
spectrum
rna
virus
antivir
role
involv
dna
virus
poorli
studi
report
rana
grylio
viru
rgv
block
virion
entri
stage
host
cell
asfv
infect
vero
cell
significantli
affect
upon
ifn
treatment
gener
sensit
toward
induct
innat
immun
respons
host
cell
led
virus
acquir
differ
strategi
regul
ifn
pathway
benefit
case
asfv
viral
gene
neg
regul
induct
ifn
target
manner
anoth
exampl
asfv
gene
codifi
viral
homolog
inhibitori
activ
ifn
final
myxoviru
resist
gene
mxa
anoth
interferon
stimul
gene
isg
also
inhibit
replic
late
gene
express
asfv
report
upon
ifn
treatment
vero
cell
distribut
ifitm
protein
chang
perinuclear
vesicular
pattern
resembl
endosom
analysi
endogen
express
absenc
ifn
induct
show
coloc
mitochondri
structur
interestingli
underw
vesicular
pattern
redistribut
around
cell
nucleu
overexpress
upon
ifn
treatment
well
character
cellular
distribut
also
unveil
specif
local
pattern
link
endosom
pathway
upon
overexpress
particularli
late
endosom
compart
distribut
coincid
previous
report
data
group
describ
local
endogen
plasma
membran
earli
endosom
late
endosom
lysosom
interestingli
overexpress
recent
describ
delay
proteolyt
degrad
human
papilloma
viru
hpv
capsid
keratinocyt
howev
affect
replic
viru
analysi
asfv
uncoat
correl
express
decreas
number
decapsid
asf
virion
vero
cell
suggest
possibl
role
inhibit
asfv
exit
late
endosom
contrast
modifi
ratio
encapsid
decapsid
virion
instead
appar
increas
accumul
virion
probabl
retain
proceed
degrad
product
infect
result
may
also
suggest
presenc
affect
releas
virion
late
endosom
compart
asfv
enter
host
cell
dynamindepend
clathrinmedi
endocytosi
macropinocytosi
fact
endosom
pathway
integr
known
import
asfv
infect
cultureadapt
isol
cell
line
virul
attenu
isol
primari
macrophag
henc
surpris
infect
could
impair
restrict
factor
act
endosom
membran
aforement
inhibit
asfv
entri
previous
report
virus
includ
iav
flavivirus
denv
wnv
filovirus
marv
ebov
coronavirus
sar
contrast
infect
alphavirus
arenavirus
mlv
retroviru
seem
unaffect
ifitm
protein
express
gener
ifitmmedi
viral
inhibit
relat
impair
viralhost
membran
fusion
subsequ
viral
bind
endocytosi
also
report
modul
fluiditi
bend
modulu
cell
membran
thu
make
resist
viral
fusion
machineri
also
studi
whether
inhibit
asfv
entri
could
due
alter
endosom
compart
analysi
endosom
distribut
upon
ifitm
overexpress
reveal
alter
normal
distribut
earli
late
endosom
lysosom
howev
alter
found
presenc
collaps
endosom
perinuclear
area
also
characterist
phenotyp
alter
endosom
cholesterol
efflux
also
recent
public
laboratori
demonstr
accumul
cholesterol
endosom
caus
chemic
inhibit
cholesterol
flux
caus
virion
retent
insid
endosom
inhibit
infect
progress
current
two
propos
model
tri
explain
ifitmmedi
inhibit
viral
entri
first
one
known
tough
membran
model
postul
intramembran
interact
adjac
ifitm
alter
fluiditi
bend
host
cellular
membran
make
resist
viral
fusion
machineri
second
model
suggest
ifitm
induc
accumul
cholesterol
endosom
membran
membran
fusion
defect
disturb
intracellular
cholesterol
homeostasi
final
block
viral
releas
cytosol
previous
report
alter
cholesterol
homeostasi
late
endosom
lead
cholesterol
accumul
block
viral
releas
present
studi
describ
accumul
cholesterol
upon
overexpress
recent
report
inhibit
cholesterol
exit
endosom
use
chemic
inhibitor
caus
retent
virion
insid
vesicl
thu
impair
progress
infect
altogeth
data
could
suggest
antivir
action
ifitm
may
affect
higher
extent
virus
requir
endosom
pathway
earli
stage
infect
collect
result
illustr
close
relationship
ifitm
protein
famili
endosom
pathway
lead
inhibit
asfv
infect
antivir
action
ifitm
could
reli
alter
endosom
physiolog
ongo
studi
laboratori
focus
antivir
target
molecular
regul
late
endosom
also
role
celltocel
viral
transmiss
postul
ifitm
incorpor
virion
perform
studi
cellular
system
use
celladapt
isol
vero
cell
result
next
extend
asfv
isol
porcin
macrophag
studi
requir
better
understand
relev
ifitm
context
asfv
infect
summari
ifitm
repres
broad
previous
unappreci
class
restrict
factor
degrad
invad
envelop
virus
may
therefor
consid
potenti
antivir
compon
protect
host
cell
